Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus
Clinical trial NCT03995212 · TERMINATED
Trial details
- NCT number
- NCT03995212
- Sponsor
- Cara Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2022-06-29
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.